In a setback for a controversial area of biotechnology, the company that led the way in trying to produce pharmaceuticals in genetically modified crops ran out of money and shut its doors on Friday.
The company, the Large Scale Biology Corp, based in Vacaville, California, said in a statement on Thursday that all of its approximately 70 employees had been let go.
Large Scale was founded in 1987 as Biosource Genetics and was apparently the first company to try to produce protein-based drugs and industrial chemicals in genetically engineered plants.
Such production, it argued, would be faster and far less expensive than using genetically engineered bacteria or animal cells, which is the usual method of producing pharmaceutical proteins like insulin and growth hormone.
But environmental groups and food companies have expressed opposition to pharmaceutical-producing crops, saying that drugs might accidentally end up in the food supply, causing health problems and forcing costly product recalls.
Large Scale used tobacco, a nonfood crop, so its technology was somewhat less controversial than that of companies using corn or rice. And under the method used by the company, the genes put into the tobacco plant could not be spread by pollen.
Still, controversy over agricultural biotechnology in general has made it difficult for small companies in that business to raise money.
Robert Erwin, a founder and the chairman of Large Scale, said the bigger problem for his company was the reluctance of drug companies to have their products developed in crops. Since there are no crop-produced pharmaceuticals on the market yet, he said, drug companies do not know how easy it will be to win approval for such drugs from the US Food and Drug Administration.
"Everybody wants to be the second one out," Erwin said. "There are very few corporate executives willing to bet on an unproven process."
Moreover, he said, pharmaceutical crop developers are wrong in assuming that lower production costs are an important consideration for drug companies.
With high prices for their drugs, Erwin said, "cost is not really an issue for them."
Large Scale's demise is a blow to Owensboro, Kentucky, in the heart of tobacco country, where Large Scale has a factory to extract drugs from the tobacco.
In the company's statement, the chief executive, Kevin Ryan, said that Large Scale was "taking steps to preserve our assets for the benefit of our creditors and stockholders."
The company said it was still in talks with potential collaborators on deals that could raise money and is also talking with potential acquirers.
The company went public at US$17 a share in 2000, the year of a biotech investing frenzy in which dozens of companies issued stock.
Even after a recent reverse split aimed at building up the price per share by reducing the number of shares, the stock closed at US$0.19 on Friday.
That was to be its last day of trading on a NASDAQ market because the company said it would not appeal a decision by NASDAQ to delist it.
Taiwan Transport and Storage Corp (TTS, 台灣通運倉儲) yesterday unveiled its first electric tractor unit — manufactured by Volvo Trucks — in a ceremony in Taipei, and said the unit would soon be used to transport cement produced by Taiwan Cement Corp (TCC, 台灣水泥). Both TTS and TCC belong to TCC International Holdings Ltd (台泥國際集團). With the electric tractor unit, the Taipei-based cement firm would become the first in Taiwan to use electric vehicles to transport construction materials. TTS chairman Koo Kung-yi (辜公怡), Volvo Trucks vice president of sales and marketing Johan Selven, TCC president Roman Cheng (程耀輝) and Taikoo Motors Group
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
RECORD-BREAKING: TSMC’s net profit last quarter beat market expectations by expanding 8.9% and it was the best first-quarter profit in the chipmaker’s history Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), which counts Nvidia Corp as a key customer, yesterday said that artificial intelligence (AI) server chip revenue is set to more than double this year from last year amid rising demand. The chipmaker expects the growth momentum to continue in the next five years with an annual compound growth rate of 50 percent, TSMC chief executive officer C.C. Wei (魏哲家) told investors yesterday. By 2028, AI chips’ contribution to revenue would climb to about 20 percent from a percentage in the low teens, Wei said. “Almost all the AI innovators are working with TSMC to address the
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”